Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data.
Future Microbiol
; 17: 1381-1391, 2022 Nov.
Article
en En
| MEDLINE
| ID: mdl-36169346
This study was designed to investigate the effectiveness of CoronaVac in preventing COVID-19 in healthcare workers (HCWs) during the alpha variant-dominant period. A total of 1911 HCWs were included. While COVID-19 developed in 4.1% of double-dose vaccinated HCWs and 11.27% of unvaccinated HCWs, the effectiveness of CoronaVac in preventing the development of COVID-19 was 65%. Compared with the results of a previous trial in Turkey, a lower effectiveness of CoronaVac against COVID-19 was detected in this real-life study. This finding suggests that mass vaccination and booster doses are needed.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
COVID-19
Tipo de estudio:
Evaluation_studies
Límite:
Humans
Idioma:
En
Año:
2022
Tipo del documento:
Article